TGFBR1 and neoplasm: Blockade of TGFBR1 signaling via the kinase inhibitor SM16, induces the accumulation at the tumor site of hypersegmented neutrophils able to directly kill tumor cells and mediate a CD8+ cell dependent immunity by the secretion of pro-inflammatory cytokines [115].